Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis

Journal of Virology

Volumn 75, Issue 17, 2001, Pages 8187-8194

  Henke, A ^a   Zell, R ^a   Ehrlich, G ^a   Stelzner, A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10;

ANIMAL TISSUE; ARTICLE; BIOASSAY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COXSACKIE VIRUS B3; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; IMMUNOREGULATION; MALE; MOUSE; MYOCARDITIS; NONHUMAN; OPEN READING FRAME; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CLONING, MOLECULAR; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HEART; INTERFERON TYPE II; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDITIS; PANCREAS; RECOMBINANT PROTEINS; VARIATION (GENETICS);

EID: 0034872765     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.17.8187-8194.2001     Document Type: Article

References (37)

1. Engineering poliovirus as a vaccine vector for the expression of diverse antigens
2. Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice
3. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
4. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
5. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis
6. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease
7. + T lymphocytes in coxsackievirus B3-induced myocarditis
8. Apoptosis in coxsackievirus B3-caused diseases: Interaction between the capsid protein VP2 and the proapoptotic protein Siva
9. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization
10. DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice
11. Expression of an antigenic adenovirus epitope in a group B coxsackievirus
12. Primary demyelination in transgenic mice expressing interferon-gamma
13. Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon
14. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis
15. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3
16. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2
17. Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus
18. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: An approach to the diagnosis of viral heart disease
19. Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage
20. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3
21. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice
22. The outcome of coxsackievirus B3 (CVB3)-induced myocarditis is influenced by the cellular immune status
23. Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy
24. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3
25. Direct myocardial injury by enterovirus: A central role in the evolution of murine myocarditis
26. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice
27. Treatment of experimental viral myocarditis with interleukin-10
28. A case for cytokines as effector molecules in the resolution of virus infection
29. Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera
30. A sensitive and specific bioassay for the detection of human interleukin-10
31. Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors Eur
32. Acquisition of lymphokine-producing phenotype by CD4+ T cells
33. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3
34. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities
35. Toward a poliovirus-based simian immunodeficiency virus vaccine: Correlation between genetic stability and immunogenicity
36. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy
37. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy